Ticker Details
Arcus Biosciences, Inc.
IPO Date:	March 12, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.86B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.66 | 3.33%
Avg Daily Range (30 D):	$0.69 | 2.45%
Avg Daily Range (90 D):	$0.76 | 2.91%

Institutional Daily Volume
Avg Daily Volume:	.58M
Avg Daily Volume (30 D):	.92M
Avg Daily Volume (90 D):	1.01M

Trade Size
Avg Trade Size (Sh.):	76
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	3,196
Avg Institutional Trade:	$2.46M
Avg Institutional Trade (30 D):	$2.97M
Avg Institutional Trade (90 D):	$2.95M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.16M
Avg Closing Trade (30 D):	$5.26M
Avg Closing Trade (90 D):	$5.78M
Avg Closing Volume:	147.55K

News

Jul 13, 2026 @ 11:09 PM An Arcus Insider Sold 68,569 Shares but Kept 1.2 M... Source: Jonathan Ponciano

Dec 2, 2024 @ 3:18 PM Biotech Advances Drive Cancer Research as Global R... Source: Prnewswire

Aug 23, 2024 @ 3:47 PM Retinoblastoma Treatment Market to Surpass $2 Bill... Source: Researchandmarkets.Com

Jul 8, 2024 @ 9:00 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights, Benzinga Staff Writer

Jun 7, 2024 @ 2:55 PM Is The Options Market Predicting a Spike In Arcus ... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.91	$-.72	$-1.02
Diluted EPS	$-3.91	$-.72	$-1.02
Revenue	$117M	$41M	$17M
Gross Profit
Net Income / Loss	$-460M	$-91M	$-128M
Operating Income / Loss	$-486M	$-96M	$-134M
Cost of Revenue
Net Cash Flow	$-98M	$-51M	$-21M
PE Ratio